Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	2252403-56-6
Formula :	C₃₀H₃₀F₂N₆O₃
M.W :	560.59
SMILES Code :	O=C1N(C2=C(C)C=CN=C2C(C)C)C3=NC(C4=C(O)C=CC=C4F)=C(F)C=C3C(N5[C@@H](C)CN(C(C=C)=O)CC5)=N1
Synonyms :	AMG-510 racemate
MDL No. :	N/A
InChI Key :	NXQKSXLFSAEQCZ-SFHVURJKSA-N
Pubchem ID :	137278711

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

LU99	5 µM	2 monthourss	Establish sotorasib-resistant cell lines to study resistance mechanisms. Resistant cells exhibited enhanced cell-matrix adhesion and activation of PAK and PI3K pathways.	Br J Cancer. 2023 Jan;128(1):148-159
LU65	5 µM	2 monthourss	Establish sotorasib-resistant cell lines to study resistance mechanisms. Resistant cells exhibited enhanced cell-matrix adhesion and activation of PAK and PI3K pathways.	Br J Cancer. 2023 Jan;128(1):148-159
MIA PaCa-2	5 µM	2 monthourss	Establish sotorasib-resistant cell lines to study resistance mechanisms. Resistant cells exhibited enhanced cell-matrix adhesion and activation of PAK and PI3K pathways.	Br J Cancer. 2023 Jan;128(1):148-159
T24	16 µM	24 hours	No inhibition of glucose metabolism observed	Am J Cancer Res. 2024 Nov 15;14(11):5251-5268
UMUC3	16 µM	24 hours	Inhibition of glucose metabolism	Am J Cancer Res. 2024 Nov 15;14(11):5251-5268
SW1463	100 nM	4 to 72 hours	Evaluate the inhibitory effect of KRASG12C inhibitors on the MAPK pathway and adaptive feedback reactivation	Cell Rep. 2022 Jun 21;39(12):110993
MIA PaCa-2	100 nM	4 to 72 hours	Evaluate the inhibitory effect of KRASG12C inhibitors on the MAPK pathway and adaptive feedback reactivation	Cell Rep. 2022 Jun 21;39(12):110993
H358	100 nM	4 to 72 hours	Evaluate the inhibitory effect of KRASG12C inhibitors on the MAPK pathway and adaptive feedback reactivation	Cell Rep. 2022 Jun 21;39(12):110993
LU65	5 µM	4-6 weeks	Establish sotorasib-resistant lung cancer cell lines and observe their growth and death after drug withdrawal.	J Biomed Sci. 2023 Jun 29;30(1):50.
NCI-H23	5 µM	4-6 weeks	Establish sotorasib-resistant lung cancer cell lines and observe their growth and death after drug withdrawal.	J Biomed Sci. 2023 Jun 29;30(1):50.
MIA PaCa-2	5 µM	4-6 weeks	Establish sotorasib-resistant pancreatic cancer cell lines and observe their growth and death after drug withdrawal.	J Biomed Sci. 2023 Jun 29;30(1):50.
H9c2 cells	0, 7.5, 15, 30, 60 µM	48 hours	To evaluate the effect of Sotorasib on cardiomyocyte viability, results showed Sotorasib significantly reduced cell viability.	Cell Death Discov. 2025 Apr 12;11(1):169
CCC-HEH-2 cells	0, 7.5, 15, 30, 60 µM	48 hours	To evaluate the effect of Sotorasib on cardiomyocyte viability, results showed Sotorasib significantly reduced cell viability.	Cell Death Discov. 2025 Apr 12;11(1):169
SW1573	9.6 µM (IC50)	72 hours	To evaluate the inhibitory effect of Sotorasib on SW1573 cells, results showed that SW1573 cells were inherently resistant to Sotorasib.	Sci Adv. 2023 Oct 13;9(41):eade3816
H23	3.2 µM (IC50)	72 hours	To evaluate the inhibitory effect of Sotorasib on H23 cells, results showed that H23 cells were tolerant to Sotorasib.	Sci Adv. 2023 Oct 13;9(41):eade3816
H358	0.13 µM (IC50)	72 hours	To evaluate the inhibitory effect of Sotorasib on H358 cells, results showed that H358 cells were highly sensitive to Sotorasib.	Sci Adv. 2023 Oct 13;9(41):eade3816

BALB/c nude mice	UMUC3 and T24 xenograft models	Gavage	10 mg/kg	Every 2 days for 14 days	Inhibition of KRASG12C mutant bladder tumor growth and expression of glucose metabolism-related proteins	Am J Cancer Res. 2024 Nov 15;14(11):5251-5268
NOD/SCID mice	Subcutaneous xenograft model	Oral gavage	10 mg/kg Sotorasib, 30 mg/kg Alpelisib, 70 mg/kg FRAX597	Daily for 14 days	Evaluate the antitumor effects of Sotorasib in combination with PAK inhibitor FRAX597 or PI3K inhibitor Alpelisib. Combination therapy significantly inhibited tumor growth.	Br J Cancer. 2023 Jan;128(1):148-159
NOD/SCID mice	Subcutaneous xenograft model	Oral	10 mg/kg/day (Sotorasib), 20 mg/kg/day (Encorafenib)	Daily administration for 14 days	Evaluate the effect of sotorasib withdrawal and BRAF inhibitor combination on tumor growth.	J Biomed Sci. 2023 Jun 29;30(1):50.
Mice	Human tumor xenograft models	Oral	100 mg/kg	Once daily for 21-28 days	Evaluate the anti-tumor effect of KRASG12C inhibitors in vivo and the combined therapeutic effect with EGFR or MEK inhibitors	Cell Rep. 2022 Jun 21;39(12):110993
NSG mice	PDO metastasis model (intracardiac injection)	Intraperitoneal	100 mg/kg	Daily administration for 5 months	Evaluate the inhibitory effect of Sotorasib on PDO metastasis. Results showed no metastatic lesions in Sotorasib-treated mice (85% PDO_12 and 37% PDO_23 developed metastases in controls).	Cell Rep Med. 2024 Oct 15;5(10):101777
Mice	PDX model	Oral and intraperitoneal injection	100mg/kg AMG510, 50mg/kg cetuximab	AMG510 once daily, cetuximab twice weekly	Evaluate the effect of AMG510 and cetuximab combination therapy, results showed significant tumor growth inhibition	Cancer Discov. 2020 Aug;10(8):1129-1139
Mice	SW1573 cell xenograft model	Oral gavage	2.5 mg/kg or 5 mg/kg	Twice a week for 16 weeks	To evaluate the antitumor effects of Sotorasib alone or in combination with CFZ in the SW1573 cell xenograft model. Results showed that the combination of Sotorasib and CFZ significantly inhibited tumor growth and improved mouse survival.	Sci Adv. 2023 Oct 13;9(41):eade3816
C57BL/6J mice	Cardiac injury model	Intragastric administration	300 mg/kg/d or 600 mg/kg/d	Once daily for 28 days	To evaluate the effect of Sotorasib on cardiac function in mice, results showed Sotorasib caused cardiac dysfunction, myocardial injury, and fibrosis.	Cell Death Discov. 2025 Apr 12;11(1):169
Mice	H358, MIA PaCa-2, and SW837 xenograft models	DT2216 intraperitoneal injection, Sotorasib oral	DT2216 15 mg/kg, Sotorasib 10 mg/kg	DT2216 every four days, Sotorasib five days a week, continuous treatment	Evaluated the antitumor efficacy of sotorasib alone or in combination with DT2216 in KRASG12C-mutated xenograft models, showing that the combination significantly inhibited tumor growth.	J Hematol Oncol. 2022 Mar 9;15(1):23

{[proInfo.proName]}

CAS No.: 2252403-56-6

{[proInfo.proName]}

CAS No.: 2252403-56-6

Alternative Products

Product Details of Sotorasib racemate

Safety of Sotorasib racemate

Related Pathways of Sotorasib racemate

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed